Altre lingue Bio-Rad Laboratories, Inc.

Azioni

BIO

US0905722072

Mercato chiuso - Nyse Altri mercati azionari 22:00:01 24/04/2024			Variaz. 5gg	Var. 1 gen.
278,2 ^USD	-2,48%		-4,35%	-13,84%

15/04	BIO-RAD LABORATORIES, INC. : Zacks Investment Research ribadisce il giudizio positivo sul titolo	ZM
11/04	Oncocyte Corporation e Bio-Rad Laboratories, Inc. collaborano al lancio globale del test sui trapianti	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18/04
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15/04
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11/04
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11/04
Bio-Rad Laboratories COO Andrew Last to Retire in September	10/04
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10/04
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10/04
North American Morning Briefing : Focus Turns to -2-	04/04
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25/03
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20/03
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as Chief Financial Officer, Effective April 15, 2024	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20/03
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29/02
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day	22/02
Bio Rad Labs rises after posting upbeat fourth-quarter profit	16/02
Bio-Rad: Q4 Earnings Snapshot	15/02
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	15/02
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Posts Q4 Revenue $681.2M, vs. Street Est of $686.6M	15/02
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Reports Q4 EPS $3.10, vs. Street Est of $2.87	15/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bio-Rad Laboratories, Inc.

Azioni

BIO

US0905722072

Altre lingue

Filtri